COVINA, CA -- (MARKET WIRE) -- February 22, 2007 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today an expansion of the clinical trial collaboration agreement between Healtheuniverse and The California Institute of Cosmetic and Reconstructive Surgery (C.I.C.R.S.). The strategic alliance is focused on the expansion of both Companies’ individual strengths leveraging Healtheuniverse’s patented stem cell technology and research and development capabilities, and C.I.C.R.S.'s clinical trial capabilities in a joint effort to commercialize the first non-embryonic stem cell therapy in the field of plastic, reconstructive, and cosmetic surgery.
